Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (11-20 of 364) with videos related to

Pageof 37
Sort By:
Oncoimmunology|July 14, 2022
A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapyOliver Kepp, Guido Kroemer
Oncoimmunology|November 27, 2020
Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!Oliver Kepp, Guido Kroemer
Oncoimmunology|December 3, 2021
Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patientsGuido Kroemer, Oliver Kepp
Oncoimmunology|November 8, 2021
Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockadeGuido Kroemer, Oliver Kepp
Autophagy|April 25, 2020
Autophagy induction by thiostrepton for the improvement of anticancer therapyOliver Kepp, Guido Kroemer
Cell Death & Disease|November 14, 2025
γδ T cells and resistance to CDK4/6 inhibitors in breast cancerOliver Kepp, Guido Kroemer
Trends in Cancer|April 26, 2022
Pro-ferroptotic fatty acid metabolism renders cancer cells immunogenicOliver Kepp, Guido Kroemer
Nature Immunology|February 16, 2011
Mitochondrial control of the NLRP3 inflammasomeOliver Kepp, Lorenzo Galluzzi, Guido Kroemer
Aging|September 30, 2010
TP53 and MTOR crosstalk to regulate cellular senescenceLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2021
Calreticulin Exposure in Mitotic CatastropheLucillia Bezu, Oliver Kepp, Guido Kroemer
Pageof 37

Showing results (11-20 of 364) with videos related to

Sort By:
Pageof 37
Oncoimmunology|July 14, 2022
A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapyOliver Kepp, Guido Kroemer
Oncoimmunology|November 27, 2020
Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!Oliver Kepp, Guido Kroemer
Oncoimmunology|December 3, 2021
Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patientsGuido Kroemer, Oliver Kepp
Oncoimmunology|November 8, 2021
Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockadeGuido Kroemer, Oliver Kepp
Autophagy|April 25, 2020
Autophagy induction by thiostrepton for the improvement of anticancer therapyOliver Kepp, Guido Kroemer
Cell Death & Disease|November 14, 2025
γδ T cells and resistance to CDK4/6 inhibitors in breast cancerOliver Kepp, Guido Kroemer
Trends in Cancer|April 26, 2022
Pro-ferroptotic fatty acid metabolism renders cancer cells immunogenicOliver Kepp, Guido Kroemer
Nature Immunology|February 16, 2011
Mitochondrial control of the NLRP3 inflammasomeOliver Kepp, Lorenzo Galluzzi, Guido Kroemer
Aging|September 30, 2010
TP53 and MTOR crosstalk to regulate cellular senescenceLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2021
Calreticulin Exposure in Mitotic CatastropheLucillia Bezu, Oliver Kepp, Guido Kroemer
Pageof 37